Skip to Content
Interactive Textbook on Clinical Symptom Research Logo


Home Button

Clinical Trials in TMD Sections
Author Bio
Introduction
The Biopsychosocial Model
Designing Multicenter RCTs
Players in an RCT
Currently selected section: Randomization
Trial Design Quality
TMD Case Definition
Endpoints and Outcome Measures
Blinding & Masking
Study Sample Size
Number and Nature of Interventions
Study Length and Follow up
Intent-to-treat Analyses and Sample Size
Compliance
Multicenter RCTs
Implementing RCTs: Practical Issues
Analysis of TMD Trials
Conclusions
Acknowledgments
Appendix A
Appendix B

 

Chapter 22: Clinical Trials in Temporomandibular: Randomization
          

Advantages of Randomization

Randomization of subjects has several unique advantages over all other current methods for assigning patients as subjects to experimental and control groups.

  • First, randomization, if properly done, removes any chance of predicting what treatment a person will receive.
  • Second, this method creates, on average, two or more groups that are equal on all known AND unknown factors. The larger the size of the randomly constituted groups, the more likely the groups will be identical on all known risk factors.

In addition, because there is a control group for comparison, factors that might contribute to pain reduction for reasons not related to the experimental treatment will be randomly distributed in both the experimental and control groups, in effect washing out the impact of unintended or unknown influences, hence controlling for "regression to the mean" phenomena that commonly occur in pain conditions.

Definition of "Regression to the Mean"

Regression to the mean is defined statistically as the tendency of extreme values to cycle around some common average value (Whitney and Von Korff, 1992).

In practical terms, when measurements include extreme values, statistical principles dictate that repeating the measurements will usually result in those extreme values coming closer (i.e., "regressing") to the overall mean value.

As a general rule, patients seek treatment at the height of their discomfort; TMD patients tend to seek treatment at the height of their TMD pain. Often the passage of time, alone, yields lower ratings of pain and pain-related sequelae, such as depression and use of medications. Patients selected from TMD clinic cases for an RCT will inevitably include those whose pain at the time of selection is atypically high. Subsequent re-measurement after treatment may reveal lower TMD pain levels, which might reflect the effect of treatment or might simply represent a regression to the mean, which could result in lowering of heightened pain levels even in the absence of treatment.

Whitney and Von Korff (1992) present an excellent discussion of this important topic with actual TMD pain data that illustrates the point very clearly.

 

Page 17 of 81
  Previous Section